• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING; RING, ANNULOPLASTY Back to Search Results
Model Number 5200
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Mitral Regurgitation (1964); Mitral Valve Stenosis (1965); Regurgitation (2259); Stenosis (2263)
Event Date 07/18/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was not returned to edwards for evaluation.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Post-operatively, the body undergoes various phases of the tissue response continuum resulting in the fibrous encapsulation of the ring.Local and systemic factors of the patient may play a role in the wound healing and inflammatory responses to biomaterials and implants.A manufacturing related issue was not identified.A definitive root cause could not be determined; however, it is likely that patient related factors contributed to the event.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
 
Event Description
It was reported via the implant patient registry that a 28mm mitral ring, implanted for two (2) years and four (4) months, was explanted due to fibrous growth, severe recurrent mitral regurgitation, and moderate stenosis.The explanted device was replaced with a 27mm bioprosthetic valve.Patient was taken to icu in satisfactory condition.Per medical records, the patient was found to have recurrent mitral regurgitation with a likely broken commissural suture, and moderate mitral stenosis with a lot of fibrinous tissue around the ring.The 28mm mitral ring was removed.After debridement, a 27mm bioprosthetic valve was implanted.Patient was weaned from cpb.Biventricular function was normal and valve functioned normally.There was good leaflet motion and no paravalvular leak.Patient was taken to icu in satisfactory condition.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARPENTIER-EDWARDS PHYSIO II ANNULOPLASTY RING
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key9010508
MDR Text Key158126028
Report Number2015691-2019-03409
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
PMA/PMN Number
K083470
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup
Report Date 08/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2020
Device Model Number5200
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-